Mercer Global Advisors
KURA icon

Mercer Global Advisors’s Kura Oncology KURA Stock Holding History

Mercer Global Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$293K Sell
36,032
-14,048
-28% -$121K ﹤0.01% 2463
2025
Q4 		$520K Buy
50,080
+17,197
+52% +$180K ﹤0.01% 1831
2025
Q3 		$291K Buy
+32,883
New +$234K ﹤0.01% 2111

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mercer Global Advisors's KURA Position: Q1 2026 in Review

Mercer Global Advisors reduced its Kura Oncology (KURA) stake by 28% in Q1 2026, selling an estimated $121K and leaving 36,032 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #2463.

Mercer Global Advisors first reported a position in KURA in Q3 2025 and has held it in 3 quarters since. The position peaked at $520K in Q4 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Mercer Global Advisors held 36,032 shares of Kura Oncology worth $293K as of Q1 2026.
  • Mercer Global Advisors sold 14,048 Kura Oncology shares in Q1 2026, an estimated $121K.
  • Kura Oncology made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #2463 holding.
  • Mercer Global Advisors first reported a position in Kura Oncology in Q3 2025 and has held it in 3 quarters since.
  • Mercer Global Advisors's Kura Oncology position peaked at $520K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.